COMPARISON OF THE CARDIOTOXICITY OF ABIRATERONE AND ENZALUTAMIDE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER USING REAL-WORLD DATA

被引：0
|
作者：
Hu, Jason
Aprikian, Armen
Vanhuyse, Marie
Dragomir, Alice
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP24-18
引用
收藏
页码：E418 / E419
页数：2
相关论文
共 50 条
  • [11] Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer
    La, Jennifer
    Wang, Lin
    Corrigan, June K.
    Lang, Deborah
    Lee, Michelle H.
    Do, Nhan V.
    Brophy, Mary T.
    Paller, Channing J.
    Fillmore, Nathanael R.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [12] Real-World Treatment Patterns Among French Patients With Metastatic Castration-Resistant Prostate Cancer Under Abiraterone or Enzalutamide
    Scailteux, Lucie-Marie
    Vincendeau, Sebastien
    Gravis, Gwenaelle
    Mathieu, Romain
    Balusson, Frederic
    Kerbrat, Sandrine
    Oger, Emmanuel
    CLINICAL GENITOURINARY CANCER, 2023, 21 (05) : E362 - E369
  • [13] A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer
    Kim, Stephanie, I
    Szeto, Andy H.
    Morgan, Katherine P.
    Brower, Blaine
    Dunn, Mary W.
    Khandani, Amir H.
    Godley, Paul A.
    Rose, Tracy L.
    Basch, Ethan M.
    Milowsky, Matthew, I
    Whang, Young E.
    Crona, Daniel J.
    PLOS ONE, 2021, 16 (06):
  • [14] Real-world comparison of abiraterone (A) versus enzalutamide (E) for first-line therapy of metastatic castration-resistant prostate cancer (mCRPC).
    Briones, Carvajal
    Juan, Rodrigo
    Naimi, Mahdi Farzad
    Zhang Liying
    Emmenegger, Urban
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [15] Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer
    Giuseppe L. Banna
    Valeria Urzia
    Chiara Benanti
    Alessandra Pitrè
    Helga Lipari
    Rosario Di Quattro
    Ugo De Giorgi
    Giuseppe Schepisi
    Umberto Basso
    Davide Bimbatti
    Francesco Rundo
    Massimo Libra
    Lorenzo Malatino
    Supportive Care in Cancer, 2020, 28 : 4687 - 4695
  • [16] Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer
    Banna, Giuseppe L.
    Urzia, Valeria
    Benanti, Chiara
    Pitre, Alessandra
    Lipari, Helga
    Di Quattro, Rosario
    De Giorgi, Ugo
    Schepisi, Giuseppe
    Basso, Umberto
    Bimbatti, Davide
    Rundo, Francesco
    Libra, Massimo
    Malatino, Lorenzo
    SUPPORTIVE CARE IN CANCER, 2020, 28 (10) : 4687 - 4695
  • [17] Abiraterone acetate in metastatic castration-resistant prostate cancer – the unanticipated real-world clinical experience
    Darren M. C. Poon
    Kuen Chan
    S. H. Lee
    T. W. Chan
    Henry Sze
    Eric K. C. Lee
    Daisy Lam
    Michelle F. T. Chan
    BMC Urology, 16
  • [18] Abiraterone acetate in metastatic castration-resistant prostate cancer - the unanticipated real-world clinical experience
    Poon, Darren M. C.
    Chan, Kuen
    Lee, S. H.
    Chan, T. W.
    Sze, Henry
    Lee, Eric K. C.
    Lam, Daisy
    Chan, Michelle F. T.
    BMC UROLOGY, 2016, 16
  • [19] Abiraterone or Enzalutamide in Advanced Castration-Resistant Prostate Cancer: An Indirect Comparison
    Chopra, Akhil
    Georgieva, Mina
    Lopes, Gilberto
    Yeo, Chong Ming
    Haaland, Benjamin
    PROSTATE, 2017, 77 (06): : 639 - 646
  • [20] Real-world effectiveness and cardiovascular safety of abiraterone versus enzalutamide amongst older patients diagnosed with metastatic castration-resistant prostate cancer
    Gaber, Charles E.
    Okpara, Ebere
    Abdelaziz, Abdullah I.
    Sarker, Jyotirmoy
    Hanson, Kent A.
    Hassan, Lubna
    Lin, Fang-Ju
    Lee, Todd A.
    Reizine, Natalie M.
    JOURNAL OF GERIATRIC ONCOLOGY, 2025, 16 (02)
12345